Superstring Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$985K Buy
+26,496
New +$1.57M 0.49% 31

Other funds holding XENE

Superstring Capital Management's XENE Position: Q3 2026 in Review

Superstring Capital Management opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 26,496 shares worth $985K. The stake represents 0.49% of the portfolio and ranks #31 among its holdings.

288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Superstring Capital Management held 26,496 shares of Xenon Pharmaceuticals worth $985K as of Q3 2026.
  • Xenon Pharmaceuticals was a new Superstring Capital Management position in Q3 2026.
  • Xenon Pharmaceuticals made up 0.49% of Superstring Capital Management's portfolio in Q3 2026, its #31 holding.
  • 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Superstring Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.